Mavroeidis Leonidas, Vassou Amalia, Zarkavelis George, Papadaki Alexandra, Mouzaki Ioanna, Ntellas Panagiotis, Gkoura Stefania, Gazouli Ioanna, Pentheroudakis George
Department of Medical Oncology, University of Ioannina, Ioannina, Greece.
Society for the Study of Clonal Heterogeneity of Neoplasia (EMEKEN), Ioannina, Greece.
Case Rep Oncol. 2020 Jan 13;13(1):1-6. doi: 10.1159/000504338. eCollection 2020 Jan-Apr.
Acquired hemophilia is a rare autoimmune bleeding disorder related to the production of autoantibodies that inhibit clotting factor VIII or IX. The underlying cause can be autoimmune disease, malignancy, pregnancy, or medications, but it is most commonly idiopathic. Here we present the case of an 81-year-old patient with locoregionally relapsed periampullary carcinoma who presented with soft tissue hematoma and an abnormally elevated activated partial thromboplastin time (aPTT) in the presence of a normal prothrombin time. A diagnosis of acquired hemophilia was established. The patient was managed with immunosuppressive prednisone and cyclophosphamide plus immunoglobulin G. He also received a cycle of chemotherapy with gemcitabine and oxaliplatin, because the underlying malignancy was the cause of the bleeding disorder. Care was complicated by neutropenia and nosocomial fever, but the patient eventually showed signs of clinical stability, while the aPTT decreased 2-fold. The patient was successfully discharged from the hospital and continued treatment in outpatient care.
获得性血友病是一种罕见的自身免疫性出血性疾病,与抑制凝血因子VIII或IX的自身抗体产生有关。潜在病因可能是自身免疫性疾病、恶性肿瘤、妊娠或药物,但最常见的是特发性的。在此,我们报告一例81岁局部区域复发的壶腹周围癌患者,该患者出现软组织血肿,凝血酶原时间正常但活化部分凝血活酶时间(aPTT)异常升高。确诊为获得性血友病。患者接受了免疫抑制性泼尼松和环磷酰胺加免疫球蛋白G治疗。由于潜在的恶性肿瘤是出血性疾病的病因,他还接受了一个周期的吉西他滨和奥沙利铂化疗。护理过程因中性粒细胞减少和医院感染性发热而复杂化,但患者最终显示出临床稳定的迹象,同时aPTT降低了2倍。患者成功出院并继续在门诊接受治疗。